OMDA logo

OMDA Omada Health

NASDAQ Global Market · Medical - Healthcare Information Services · Healthcare

$24.04
-0.33 (-1.35%)

Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.

Market Cap: $1.43Bwww.omadahealth.com

Price (90d)

$23.67
$14.58$17.68$20.79$23.89
Apr 30Aug 7

Signal Score (90d)

107
100102104107
Aug 7Aug 12

Quote

Day Range
$23.84 – $24.92
52-Week Range
$10.28 – $26.91
Volume
$948.4K
Market Cap
$1.43B
50-Day Avg
$20.91
200-Day Avg
$16.91
Prev Close
$24.37
Open
$24.79

Valuation & Ratios

P/E Ratio
-71.73
EPS
$-0.22
P/B Ratio
4.01
P/S Ratio
3.54
Debt/Equity
0.00
Current Ratio
3.60
Dividend Yield
+0.0%
Gross Margin
+65.7%

Returns & Efficiency

Return on Equity
-5.6%
Return on Assets
-4.2%
FCF Yield
+1.8%
EV/EBITDA
-147.27

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$260.21M$-12.78M$-0.22
2024$169.80M$-47.14M$-0.85
2023$122.78M$-67.51M$-1.21
2022$89.19M$-72.52M$-1.30

Social Signal Score

55
5d
57
1 mentions
+0.0%
30d
54
2 mentions
+0.0%
60d
54
2 mentions
+38.3%
90d
54
2 mentions
+42.9%
news: 2

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $0.07 per share

5of 6 quarters beat consensus

Typical surprise +76.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$0.15 vs $0.06beat
  • Thu, May 7$0.01 vs $-0.08beat
  • Thu, Mar 5$0.13 vs $0.03beat
  • Thu, Nov 6$-0.06 vs $-0.10beat
  • Thu, Aug 7$-0.09 vs $-0.10beat
  • Fri, May 9$-0.13 vs $-0.12miss

Estimates and results for OMDA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

OMDAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsseekingalpha.com·3d ago·Neutral

    Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA's product expansion, especially in diabetes and hypertension, is driving higher revenue per member and improving customer-lifetime-value through multi-program adoption. Channel partnerships with PBMs and health plans are lowering CAC, supporting scalable growth and better unit

    View source ↗
  • Newszacks.com·7d ago·Neutral

    Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

    View source ↗